Why the study?
The study was conducted to evaluate the feasibility of vascular plaque quantification to evaluate carotid atherosclerotic plaques and observe the effect of statins on them.
Does moderate-intensity statin treatment improve carotid plaque stability as measured by gray scale median (GSM) using VPQ in patients with carotid plaques?
Does moderate-intensity statin treatment improve carotid plaque stability as measured by gray scale median (GSM) using VPQ in patients with carotid plaques?
Vascular plaque quantification (VPQ) using 3D ultrasound is feasible for evaluating carotid plaque stability and demonstrates that moderate-intensity statin therapy increases plaque echogenicity (GSM) over two years.
Hypothesis-generating for VPQ monitoring of statin effects on carotid plaques; prospective validation required before clinical use.
OBJECTIVE: To analyze the feasibility of using vascular plaque quantification (VPQ) to evaluate carotid atherosclerotic plaques and to observe the effect of statins on carotid atherosclerotic plaques. METHODS: Patients with carotid plaques from January 2016 to September 2018 in Peking University First Hospital Neurology Department were recruited and underwent three-dimonsional ultrasound (3DUS). Their gray scale median (GSM) and other parameters of carotid plaques were measured with VPQ. The patients were divided into low GSM group (GSM < 40) and high GSM group (GSM≥40). The clinical characteristics and plaque characteristics of the patients in the two groups were compared to analyze the stability of plaques. According to whether taking statins or not, the patients were further divided into statin group and non-statin group, plaque GSM and other parameters of their carotid plaques were measured and the changes of carotid plaques at the end of 3 months and 2 years were observed. CONCLUSION: The VPQ technology of 3DUS can be used to evaluate carotid atherosclerotic plaques. Patients with low GSM (GSM < 40) have more severe vascular stenosis and higher normalized wall index. VPQ technology can also be used to observe the effect of statins on carotid plaque, the GSM of plaques increase in patients who are taking moderate-intensity statin treatment for two years.
No takes yet. Share an insight, caveat, or question.
Xing et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: